Inovio Pharmaceuticals Inc (INO)
4.065
+0.10
(+2.39%)
USD |
NASDAQ |
Nov 21, 16:00
4.065
0.00 (0.00%)
After-Hours: 20:00
Inovio Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -31.99K% |
| March 31, 2024 | |
| December 31, 2023 | -24.36K% |
| September 30, 2023 | -8.73K% |
| June 30, 2023 | -15.73K% |
| March 31, 2023 | -35.36K% |
| December 31, 2022 | -43.69K% |
| September 30, 2022 | -412.8% |
| June 30, 2022 | -13.83K% |
| March 31, 2022 | -39.72K% |
| December 31, 2021 | -12.75K% |
| September 30, 2021 | -20.63K% |
| June 30, 2021 | -30.11K% |
| March 31, 2021 | -14.66K% |
| December 31, 2020 | -436.1% |
| September 30, 2020 | |
| June 30, 2020 | -48.17K% |
| March 31, 2020 | -2.45K% |
| December 31, 2019 | -13.48K% |
| September 30, 2019 | -2.66K% |
| June 30, 2019 | -21.66K% |
| March 31, 2019 | -1.03K% |
| December 31, 2018 | -1.32K% |
| September 30, 2018 | -1.25K% |
| June 30, 2018 | -27.16% |
| Date | Value |
|---|---|
| March 31, 2018 | -2.11K% |
| December 31, 2017 | -244.7% |
| September 30, 2017 | -1.29K% |
| June 30, 2017 | -46.44% |
| March 31, 2017 | -222.5% |
| December 31, 2016 | -308.1% |
| September 30, 2016 | -165.5% |
| June 30, 2016 | -301.5% |
| March 31, 2016 | -99.17% |
| December 31, 2015 | -302.4% |
| September 30, 2015 | 23.13% |
| June 30, 2015 | -118.2% |
| March 31, 2015 | -204.8% |
| December 31, 2014 | -301.6% |
| September 30, 2014 | -390.0% |
| June 30, 2014 | -281.8% |
| March 31, 2014 | -459.0% |
| December 31, 2013 | -888.4% |
| September 30, 2013 | -325.5% |
| June 30, 2013 | -1.38K% |
| March 31, 2013 | -607.7% |
| December 31, 2012 | -58.05% |
| September 30, 2012 | -774.8% |
| June 30, 2012 | -947.8% |
| March 31, 2012 | -487.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-48.17K%
Minimum
Jun 2020
-412.8%
Maximum
Sep 2022
-20.97K%
Average
-15.73K%
Median
Jun 2023
Profit Margin (Quarterly) Benchmarks
| Novavax Inc | -143.5% |
| Baxter International Inc | 5.19% |
| AIM ImmunoTech Inc | -10.57K% |
| Protalix BioTherapeutics Inc | 18.02% |
| Armata Pharmaceuticals Inc | -- |